Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japan’s Teijin Sues Towa Over Generic Too Similar To Teijin Drug

This article was originally published in PharmAsia News

Executive Summary

Two Japanese drug makers are involved in a legal battle over a generic maker's container design, which the suing company says was too similar to its own. Teijin Pharma filed the suit against Towa Pharmaceutical over its generic to Teijin's hay fever treatment, Rhinocort Powder Spray for Nasal Use. The suit accuses Towa of unfair competition by mimicking its packaging and method for dispensing the drug, which are too much like Teijin's. Teijin seeks an injunction and nearly $88,000 in damages. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts